516 related articles for article (PubMed ID: 33709421)
1. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines.
Foster M; Hill PC; Setiabudiawan TP; Koeken VACM; Alisjahbana B; van Crevel R
Immunol Rev; 2021 May; 301(1):122-144. PubMed ID: 33709421
[TBL] [Abstract][Full Text] [Related]
2. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
3. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
[TBL] [Abstract][Full Text] [Related]
4. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
5. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
[TBL] [Abstract][Full Text] [Related]
8. Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
Pi J; Zhang Z; Yang E; Chen L; Zeng L; Chen Y; Wang R; Huang D; Fan S; Lin W; Shen H; Xu JF; Zeng G; Shen L
J Nanobiotechnology; 2022 Jan; 20(1):36. PubMed ID: 35033108
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
10. Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4
Das S; Marin ND; Esaulova E; Ahmed M; Swain A; Rosa BA; Mitreva M; Rangel-Moreno J; Netea MG; Barreiro LB; Divangahi M; Artyomov MN; Kaushal D; Khader SA
mBio; 2021 Aug; 12(4):e0146821. PubMed ID: 34253059
[TBL] [Abstract][Full Text] [Related]
11. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
[TBL] [Abstract][Full Text] [Related]
12. BCG: From veins to correlates.
Suliman S
Cell Host Microbe; 2023 Jun; 31(6):921-923. PubMed ID: 37321176
[TBL] [Abstract][Full Text] [Related]
13. BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.
Tangie E; Walters A; Hsu NJ; Fisher M; Magez S; Jacobs M; Keeton R
Immunology; 2022 Feb; 165(2):219-233. PubMed ID: 34775598
[TBL] [Abstract][Full Text] [Related]
14. A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis.
O'Hara JM; Wakabayashi S; Siddiqi N; Cheung E; Babunovic GH; Thompson CM; Lu YJ; Rubin EJ; Malley R; Zhang F
mBio; 2023 Feb; 14(1):e0361122. PubMed ID: 36749098
[TBL] [Abstract][Full Text] [Related]
15. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
Coppola M; Ottenhoff TH
Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
[TBL] [Abstract][Full Text] [Related]
16. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
[TBL] [Abstract][Full Text] [Related]
17. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
Boggiano C; Eichelberg K; Ramachandra L; Shea J; Ramakrishnan L; Behar S; Ernst JD; Porcelli SA; Maeurer M; Kornfeld H
Vaccine; 2017 Jun; 35(27):3433-3440. PubMed ID: 28476627
[TBL] [Abstract][Full Text] [Related]
18. A review of the BCG vaccine and other approaches toward tuberculosis eradication.
Cho T; Khatchadourian C; Nguyen H; Dara Y; Jung S; Venketaraman V
Hum Vaccin Immunother; 2021 Aug; 17(8):2454-2470. PubMed ID: 33769193
[TBL] [Abstract][Full Text] [Related]
19.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
20. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]